State Street Corp United Therapeutics Corp Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, State Street Corp holds 2,238,224 shares of UTHR stock, worth $815 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,238,224
Previous 2,294,233 2.44%
Holding current value
$815 Million
Previous $731 Million 9.75%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $17.4 Million - $20.4 Million
-56,009 Reduced 2.44%
2,238,224 $802 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $82 Million - $115 Million
359,114 Added 18.56%
2,294,233 $731 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $2.54 Million - $3.01 Million
-12,058 Reduced 0.62%
1,935,119 $445 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $14.6 Million - $17.4 Million
67,907 Added 3.61%
1,947,177 $428 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $743,911 - $871,818
3,512 Added 0.19%
1,879,270 $424 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $16.5 Million - $18.8 Million
80,656 Added 4.49%
1,875,758 $414 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $52.3 Million - $67.9 Million
245,747 Added 15.86%
1,795,102 $402 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $9.61 Million - $13.1 Million
-46,662 Reduced 2.92%
1,549,355 $431 Million
Q3 2022

Nov 15, 2022
BUY
$203.3 - $244.17 $5.05 Million - $6.06 Million
24,822 Added 1.58%
1,596,017 $334 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $9.67 Million - $13.3 Million
-55,296 Reduced 3.4%
1,571,195 $370 Million
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $18.1 Million - $23.4 Million
109,226 Added 7.2%
1,626,491 $292 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $10 Million - $11.8 Million
54,462 Added 3.72%
1,517,265 $328 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $854,694 - $1.02 Million
4,752 Added 0.33%
1,462,803 $270 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $13.3 Million - $16.5 Million
77,964 Added 5.65%
1,458,051 $262 Million
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $24.5 Million - $27.9 Million
-159,395 Reduced 10.35%
1,380,087 $231 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $3.11 Million - $4.63 Million
30,491 Added 2.02%
1,539,482 $234 Million
Q3 2020

Nov 10, 2020
SELL
$99.9 - $121.13 $464,734 - $563,496
-4,652 Reduced 0.31%
1,508,991 $152 Million
Q2 2020

Aug 14, 2020
SELL
$92.74 - $125.82 $37.4 Million - $50.7 Million
-402,889 Reduced 21.02%
1,513,643 $183 Million
Q1 2020

May 11, 2020
BUY
$79.39 - $115.35 $152 Million - $221 Million
1,916,532 New
1,916,532 $182 Million

Others Institutions Holding UTHR

# of Institutions
668
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email